Peritoneal Dialysis in Infants: A Lifeline for Tiny Patients
"Exploring the long-term survival and challenges of peritoneal dialysis in children under two."
Chronic kidney disease (CKD) in infants presents unique challenges, with peritoneal dialysis (PD) often serving as the primary treatment method. PD offers several advantages, including the ability to be performed at home, preserving residual kidney function, and granting greater autonomy for both the child and their family. This approach is favored over hemodialysis, which can be more difficult to manage in young children due to vascular access issues and the need for specialized centers.
While CKD in the first two years of life is rare, it necessitates specialized care. Recent data from the European Society for Paediatric Nephrology (ESPN) indicates a prevalence of 20.6 per million children under four years of age. Infants undergoing PD represent a significant portion of the pediatric dialysis population, facing a higher risk of complications such as peritonitis and catheter-related infections.
This article delves into a retrospective study examining the long-term outcomes of infants who began PD before their second birthday. The study analyzes survival rates, growth patterns, and developmental milestones, offering insights into the effectiveness and challenges of this life-sustaining treatment. The goal is to provide families and healthcare professionals with a comprehensive understanding of PD in infants, empowering them to make informed decisions and optimize care strategies.
What are the main challenges and outcomes of peritoneal dialysis in infants?
A retrospective study conducted at a Portuguese pediatric nephrology unit between 1991 and 2014, sheds light on the experiences of 20 infants who initiated PD before the age of two. The study evaluated various factors, including the causes of kidney failure, mortality rates, complications, growth patterns, and psychomotor development.
- Peritonitis: The most frequent cause of hospitalization, highlighting the ongoing challenge of infection control in PD.
- Growth Impairment: Children remaining on PD experienced stunted growth, underscoring the need for optimized nutritional strategies.
- Kidney Transplantation: Ten children successfully underwent kidney transplantation at an average age of 5.3 years, demonstrating the potential for long-term survival and improved outcomes.
- Developmental Delays: A significant proportion (64%) exhibited neurodevelopmental delays, indicating the complex interplay between kidney disease and overall development.
Research on Dialysis and Cognition
A Nature Reviews Nephrology listing dated April 24, 2025, describes authors considering how dialysis treatment, including hemodialysis and peritoneal dialysis, may relate to accelerated cognitive impairment in people with kidney failure. The listing says dialysis has been implicated; it does not establish causation. The snippet does not provide infant-specific findings.
Limits in Infant Outcome Data
An infant dialysis outcomes study notes that it could not control for unmeasured confounders absent from the Registry database and had missing data, including comorbid conditions. In the Italian Registry study, growth analysis included only infants with complete auxological parameters at 0, 6, and 12 months of follow-up. These limitations are relevant when interpreting the reported outcomes and growth data.
Peritonitis Rates in Infants
The SCOPE collaborative report examined peritonitis following maintenance peritoneal dialysis catheter placement during infancy. It reported an in-hospital annualized rate of 1.73 episodes per patient-year and an overall annualized rate of 0.76 episodes per patient-year. The report distinguishes these as in-hospital and overall rates.
Looking Ahead: Optimizing Care and Improving Outcomes
This research reinforces the value of PD as a viable option for infants with kidney failure, even from birth. However, it also underscores the critical need for ongoing research and development to minimize complications, promote healthy growth, and support neurodevelopment. By focusing on these key areas, healthcare professionals can improve the long-term outcomes and quality of life for these vulnerable patients.
Residual Kidney Function
A meta-analysis on peritoneal dialysis describes residual kidney function as affecting patients’ survival and quality of life, and says it examined risk and protective factors associated with its decline. A 2026 narrative review likewise calls residual kidney function important to outcomes, citing its contributions to solute clearance, volume regulation, reduced inflammation, and improved survival. That review also reports that residual kidney function commonly declines after peritoneal dialysis begins and that potentially modifiable factors may contribute.
Challenges in Peritoneal Dialysis
A 2017 review says that, despite gradual global growth in peritoneal dialysis use, several areas need attention and improvement. It identifies technique failure and sustaining long-term treatment as challenges, alongside managing and preventing peritoneal infections. The review also lists malnutrition, inflammation, and cardiovascular issues among areas requiring attention.
Outcomes Across Countries
A global study published in 2024 describes kidney failure treated with hemodialysis or peritoneal dialysis as a major health problem associated with increased risks of death and hospitalization. It aimed to compare the incidence and causes of death and hospitalization during the first year of either treatment across countries. The provided description focuses on country-level comparisons rather than infant-specific outcomes.